Article (Scientific journals)
Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules
Stevenson, JC; GASPARD, Ulysse; Avouac, B et al.
1998In Climacteric: the Journal of the International Menopause Society, 1, p. 12-17
Peer Reviewed verified by ORBi
 

Files


Full Text
Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules.pdf
Publisher postprint (521.78 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
General & internal medicine
Author, co-author :
Stevenson, JC
GASPARD, Ulysse ;  Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique
Avouac, B
Bricaire, C
Cardozo, L
Collins, P
Devogelaer, JP
Dören, M
Gennari, C
Kaufman, JM
Kuttenn, F
Ringe, JD
Scarafiotti, C
Vanhaelst, L
Zichella, L
Ziegler, R
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
More authors (7 more) Less
Language :
English
Title :
Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules
Publication date :
1998
Journal title :
Climacteric: the Journal of the International Menopause Society
ISSN :
1369-7137
eISSN :
1473-0804
Publisher :
Taylor & Francis Ltd, Lancaster, United Kingdom
Volume :
1
Pages :
12-17
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 26 October 2012

Statistics


Number of views
46 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
4
Scopus citations®
without self-citations
4
OpenCitations
 
2

Bibliography


Similar publications



Contact ORBi